Health ❯Healthcare ❯Public Health

HIV Prevention

Clinical Trials Lenacapavir PrEP Transgender Care

New Biannual HIV Injection Reduces Infection Risk by 96%

Lenacapavir Injection Shows 96% Efficacy in Preventing HIV